Johnson & Johnson aims to produce a billion doses of COVID-19 vaccine
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate on which it expects to initiate human clinical studies by September at the latest with the first batches of the vaccine available for emergency use authorization in early 2021. In addition, the company announced the significant expansion of the existing partnership between […]
